Download PDF

Dr. Mark Socinski covered the TAILOR trial, an Italian study directly comparing second line Taxotere (docetaxel) to Tarceva (erlotinib) in advanced NSCLC patients without an EGFR mutation, in the ASCO Lung Cancer Highlights program.  However, as a preview to his comments you’ll find in the podcast here, I’ll share that he wasn’t fond of the trial or the questionable value of the results from it.  

Still, the trial is among the ones likely to be most discussed in the field of lung cancer from ASCO 2012, so it’s worth hearing what it showed, along with an expert perspective of how to interpret it.  Below, you’ll find the audio and video versions of the podcast along with the transcript and figures.

Podcast: Play in new window | Download (Duration: 7:08 — 26.0MB) | Embed

Dr. Socinski ASCO LC Highlights 2012 TAILOR Trial Audio Podcast

Dr. Socinski ASCO LC Highlights 2012 TAILOR Trial Transcript

Dr. Socinski ASCO LC Highlights 2012 TAILOR Trial Figs

We’ll finish Dr. Socinski’s presentation of ASCO Highlights in Lung Cancer with his summary of some work in small cell lung cancer. Look for that soon.